US Map / Massachusetts
State MA

Clinical Trials in Massachusetts

Massachusetts is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Massachusetts and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 474 actively recruiting studies with Massachusetts sites out of 474 registered in total. The busiest research areas in Massachusetts are Prostate Cancer, Colorectal Cancer, Breast Cancer. Leading sponsors running trials in the state include Massachusetts General Hospital, Brigham and Women's Hospital, Boston Children's Hospital. By stage, Massachusetts trials break down as Phase 1 (86), Phase 2 (125), Phase 3 (78), Phase 4 (14).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
474
Recruiting Now
474
← Back to US Map
Top Conditions in Massachusetts
Prostate Cancer (8)Colorectal Cancer (7)Breast Cancer (7)Cancer (6)Solid Tumor (6)Heart Failure (6)Lung Cancer (6)Advanced Solid Tumors (6)Multiple Myeloma (6)Schizophrenia (5)Acute Myeloid Leukemia (5)Healthy (5)

Frequently Asked Questions — Clinical Trials in Massachusetts

How many clinical trials are currently recruiting in Massachusetts?
ClinicalMetric currently tracks 474 actively recruiting clinical trials with at least one location in Massachusetts. The total number of registered studies—including active but not currently enrolling trials—is 474. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Massachusetts?
Massachusetts hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Colorectal Cancer, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Massachusetts serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Massachusetts?
To join a clinical trial in Massachusetts, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Massachusetts maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Massachusetts

NCT06127199 N/A
Recruiting
Contraceptive Efficacy Study of Ovaprene
Condition
Contraception
Enrollment
656 pts
Location
United States
Sponsor
Daré Bioscience, Inc.
View Trial →
NCT04299828 N/A
Recruiting
Evaluation of Pro-Inflammatory Leukocyte Activity in Patients Undergoing Cardiac...
Condition
Congenital Heart Disease
Enrollment
100 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT04880265 N/A
Recruiting
Assessing the Burden of Perioperative Atrial Fibrillation in Patients Undergoing...
Condition
Atrial Fibrillation
Enrollment
150 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
View Trial →
NCT01401998 N/A
Recruiting
ARPKD Database Study
Condition
Hepato/Renal Fibrocystic Disease
Enrollment
200 pts
Location
United States
Sponsor
Children's Hospital of Philade
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07818707 Phase 4
Recruiting
Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Baria...
Condition
Hypoglycemia
Enrollment
40 pts
Location
United States
Sponsor
Joslin Diabetes Center
View Trial →
NCT07072039 N/A
Recruiting
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
75 pts
Location
United States
Sponsor
University of Massachusetts, W
View Trial →
NCT06472245 Phase 3
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung...
Condition
Patients With Non-Small Cell Lung Cancer
Enrollment
363 pts
Location
United States, Belgium, Canada
Sponsor
OSE Immunotherapeutics
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT07061951 Phase 2
Recruiting
Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Rel...
Condition
Recurrent Chronic Lymphocytic Leukemia
Enrollment
20 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06664151 EARLY_Phase 1
Recruiting
A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immuniz...
Condition
Skin Cancer
Enrollment
25 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT04429542 Phase 1
Recruiting
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therap...
Condition
Head and Neck Squamous Cell Carcinoma
Enrollment
473 pts
Location
United States, Australia, Canada
Sponsor
Bicara Therapeutics
View Trial →
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
View Trial →
NCT05420051 N/A
Recruiting
Boosting Emotional Well-being and Happiness in Outpatients Living With Diabetes
Condition
Diabetes Mellitus, Type 2
Enrollment
280 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT07300969 Phase 2
Recruiting
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Condition
Major Depressive Disorder (MDD)
Enrollment
300 pts
Location
United States, Bulgaria, Czechia
Sponsor
Draig Therapeutics Ltd
View Trial →
NCT07232641 N/A
Recruiting
Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Ch...
Condition
Substance Use Disorders
Enrollment
185,810 pts
Location
United States
Sponsor
Boston University
View Trial →
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
View Trial →
NCT05103566 N/A
Recruiting
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS)...
Condition
Subarachnoid Hemorrhage, Aneurysmal
Enrollment
25 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT06338774 N/A
Recruiting
Cognitive Control to Boost Physical Activity Adherence
Condition
Physical Inactivity
Enrollment
264 pts
Location
United States
Sponsor
University of Iowa
View Trial →
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
View Trial →
NCT07130786 Phase 2
Recruiting
Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients ...
Condition
Seizures
Enrollment
150 pts
Location
United States
Sponsor
Ayal A. Aizer, MD
View Trial →
NCT07870395 N/A
Recruiting
Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
Condition
Heart Failure
Enrollment
450 pts
Location
United States
Sponsor
Noah Labs
View Trial →
Page 2 of 19 — 474 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology